...
首页> 外文期刊>Patient Preference and Adherence >Factors associated with the use of percutaneous coronary intervention in elderly Chinese patients with a first ST elevated acute myocardial infarction
【24h】

Factors associated with the use of percutaneous coronary intervention in elderly Chinese patients with a first ST elevated acute myocardial infarction

机译:中国老年首发ST升高的急性心肌梗死患者经皮冠状动脉介入治疗的相关因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Rapid reperfusion therapies (RT), particularly percutaneous coronary intervention (PCI), improve short- and long-term outcomes in patients with ST segment elevation myocardial infarction (STEMI). However, a substantial proportion of patients with STEMI, especially older patients, refuse or do not undergo PCI. Our study aims to identify factors associated with the use of PCI in elderly Chinese patients with their first STEMI. Method: Elderly (aged 65 years of age or over) patients with STEMI were enrolled between March 2010 and August 2013 at two hospitals in Beijing. Patients with previous myocardial infarction and those with contraindications to reperfusion were excluded. A standardized questionnaire including onset time and severity of symptoms, history of angina pectoris, comorbid illnesses, functional status, family income, health insurance, education, patients' trust in treating physicians, and whether patient was acquainted with a cardiologist was used to collect data from patients or their family. Results: Five hundred and sixty-eight patients were enrolled. PCI was accepted by 432 (76%) and refused by 136 (24%). Multivariate analysis showed that older age (>75 years; odds ratio [OR], 0.57; 95% confidence interval [CI], 0.23–0.78), self-rated mild symptoms (OR, 0.12; 95% CI, 0.06–0.21), lower degree of trust in treating physician (<6 in a 10 point scale; [OR, 0.14; 95% CI, 0.09–0.28]), and not being acquainted with a cardiologist (OR, 0.28; 95% CI, 0.07–0.42) were associated with refusal of PCI. Conclusion: PCI was refused by almost one quarter of eligible elderly Chinese patients with a first STEMI. Age, symptom severity, and trust in physician were independent factors associated with the use of PCI in these patients.
机译:简介:快速再灌注疗法(RT),尤其是经皮冠状动脉介入治疗(PCI),可改善ST段抬高型心肌梗死(STEMI)患者的短期和长期结局。但是,很大一部分STEMI患者,尤其是老年患者拒绝或不接受PCI。我们的研究旨在确定与中国首例STEMI的老年患者使用PCI相关的因素。方法:于2010年3月至2013年8月之间在北京的两家医院纳入老年STEMI(65岁或以上)患者。排除先前有心肌梗塞的患者和有再灌注禁忌症的患者。收集包括发病时间和症状严重程度,心绞痛史,合并症,功能状态,家庭收入,健康保险,教育,患者对内科医生的信任以及患者是否熟悉心脏病专家的标准化问卷来自患者或其家人。结果:568例患者入选。 PCI被432(76%)接受,被136(24%)拒绝。多因素分析显示,年龄较大(> 75岁;优势比[OR]为0.57; 95%置信区间[CI]为0.23-0.78),自我评估的轻度症状(OR为0.12; 95%CI为0.06-0.21) ,对医生的信任度较低(在10分制中<6; [OR,0.14; 95%CI,0.09–0.28]),并且不熟悉心脏病专家(OR,0.28; 95%CI,0.07–9) 0.42)与PCI拒绝有关。结论:将近四分之一的患有首次STEMI的中国老年患者拒绝了PCI。年龄,症状严重程度和对医生的信任是与这些患者使用PCI相关的独立因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号